TAG:
laboratories
Anatomic Path Insourcing Expected to Be Ongoing
By Robert Michel | From the Volume XVIII No. 16 – November 28, 2011 Issue
CEO SUMMARY: Insourcing of anatomic pathology services by office-based physicians has been especially prevalent and is increasing among three specialties (gastroenterology, urology, and dermatology), according to a survey conducted last month. Survey respondents also indicated that the tr…
November 28, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 16 – November 28, 2011 Issue
Here’s an interesting window on the true uptake of telemedicine and Internet access. In Oklahoma, the cost of this subsidized service was $28 million in 2009. That cost climbed to $52 million in 2010. Of that total, $19 million was the cost of telemedicine. In Oklahoma City, The Oklahoman …
Clin Lab Partners’ Strategy Is to Leverage Lab Data
By Robert Michel | From the Volume XVIII No. 15 – November 7, 2011 Issue
CEO SUMMARY: At Clinical Laboratory Partners, the strategy is to create and deliver a growing suite of enhanced lab information services to client physicians and payers in the Connecticut market. It wants to differentiate itself from competing lab companies by packaging lab test …
November 7, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 15 – November 7, 2011 Issue
Many experts were impressed when General Electric Co. ponied up $587 million to acquire pathology testing company Clarient, Inc., in October 2010. Now comes further insight behind this transaction. At an investment conference in Boston on November 3, John Dineen, CEO…
Lab Testing, Pathology Is Fast-Growing in China
By Robert Michel | From the Volume XVIII No. 15 – November 7, 2011 Issue
CEO SUMMARY: It was record attendance at the major pathology congress which took place in Hangzhou, China, last month. Because of the ongoing growth of China’s economy, the demand for healthcare—and for high-quality clinical lab and pathology testing—is rising at an accelerated pace…
At Kaiser Permanente, Real-Time Lab Results Are a Hit with Patients
By Robert Michel | From the Volume XVIII No. 15 – November 7, 2011 Issue
CEO SUMMARY: Should patients be allowed to see their own lab test results when they are available to their physicians? Kaiser Permanente believes so. Since 2005, Kaiser Permanente has given members real-time access to most laboratory test results in their personal health record (PHR) on w…
Medicare Carrier Plans to Reject Molecular Claims
By Robert Michel | From the Volume XVIII No. 15 – November 7, 2011 Issue
CEO SUMMARY: In September, Palmetto, a Medicare carrier serving California and seven other states, made public two draft local coverage determinations (LCDs) that revamp its coverage guidelines for molecular diagnostic tests (MDT) and laboratory-developed tests (LDT). All labs su…
Economics of Lab Testing to Be Challenged
By R. Lewis Dark | From the Volume XVIII No. 15 – November 7, 2011 Issue
BY ANY MEASURE, 2012 IS SHAPING UP TO BE A YEAR OF MAJOR CHANGE for healthcare and the clinical laboratory testing industry. Unfortunately, an early reading of the tea leaves indicates that the outcomes are not likely to be favorable for most clinical laboratories and anatomic pathology groups. Letâ…
Abbott Says It Will Split into Two Firms in 2012
By Robert Michel | From the Volume XVIII No. 15 – November 7, 2011 Issue
FURTHER CHANGES ARE COMING to the in vitro diagnostics (IVD) marketplace. On October 19, Abbott Laboratories, Inc., announced that it would separate into two publicly-traded companies sometime in 2012. One business will be the medical devices and diagnostics business. It w…
October 17, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 14 – October 17, 2011 Issue
Have you ever heard the term “digital PCR†(Polymerase Chain Reaction)? That technology was of such interest to Bio-Rad Laboratories, Inc., that it just paid $162 million to acquire QuantaLife, Inc., the company that developed this digital PCR technology. The dea…
CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized